SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs upcoming decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders citing the amended upper-limb data, rare-disease policy discussions and recent launch-related hiring as reasons for optimism. Others caution that approval is uncertain given the prior negative review and continuing questions about the evidence.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens strong quarterly results and rapid PAPZIMEOS commercial uptake are driving attention, with traders highlighting the companys return to profitability and potential for further growth. The upbeat reaction is accompanied by short-squeeze speculation and interest in upcoming PRGN-2009 data and European expansion.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A run to a 52-week high has traders positioning around the expected Q3 earnings report, with BRIUMVIs sales growth supporting optimism. Buyout rumors and heavy short interest are fueling squeeze speculation, though some traders see earnings expectationsnot a confirmed acquisitionas the main driver.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths post-TDAPA Medicare add-on could fall sharply after Q1 2027 has fueled concerns about pricing and CorMedix revenue amid a steep selloff. Traders dispute whether DaVitas preliminary outlook signals a broader reimbursement decline, pointing to CMSs published estimate, while others criticize management for not clarifying the potential impact.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL leukemia trial reached its prespecified 80th death event, triggering final analysis and putting the GPS survival readout at the center of discussion. Traders are divided between optimism about a strong result and concerns about the control arm and trial design, while shares have come under pressure ahead of the binary catalyst.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is under pressure after a steep decline, with traders focused on analyst price-target cuts and uncertainty ahead of its earnings report, as well as concerns about digital-ad growth. Bulls argue the selloff is disconnected from the companys profitability and growth, while bears warn of more downside if results or guidance disappoint; some also point to broader tech-market weakness.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp technology and AI-linked selloffintensified by Intels weak outlook and concerns about returns on heavy AI investmentis driving attention to QQQ. Traders are split between warning of more downside and treating the drop as an oversold dip with potential for a rebound.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure amid a semiconductor and tech selloff, as traders question whether heavy AI infrastructure spending will generate adequate returns; weak Intel guidance and concerns about Amazons elevated capex are cited as contributing pressures. The community is divided between expecting a deeper unwind in the AI trade and seeing oversold conditions and technical support as possible grounds for a bounce.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas strong quarterly results and raised outlook, alongside expectations that AI agents will increase demand for identity security, fueled a sharp rally. Traders are now debating whether the growth outlook justifies the valuation, with some taking profits or positioning for a pullback.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by growth in Eylea HD and Sanofi collaboration revenue from Dupixent, drove a sharp share-price gain. Traders largely celebrated the earnings beat and breakout, while some pointed to the upcoming cemdisiran decision as another potential catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Smartbird Stock's Momentum Score Surges As Allbirds Rebrand, AI Infrastructure Pivot And New CEO Hire Ignite Rally

Smartbird, formerly Allbirds, saw a sharp surge in its momentum score amid rebrand as an AI company with a new CEO.read more...

Why Is Smartbird Stock Surging Thursday?

Smartbird (NASDAQ: BIRD) stock jumps as the company completes its shift from footwear to AI infrastructure. Read the latest updates.read more...

BIRD Stock To Finally Take Flight? Allbirds Rebrands To Smartbird To Double Down On AI Pivot, Ignites Retail Optimism

Equity

The company changed its name, appointed a new CEO, and expanded its capital pool. 


Why Is Smartbird Stock Gaining Wednesday?

Smartbird ($BIRD) stock surges 45% after rebranding from Allbirds and shifting its focus to AI infrastructure. Read the major updates.read more...

Allbirds continues AI pivot with name change and CEO hire, sending stock soaring

Allbirds became NewBird AI in April and said it would trade shoes for AI compute infrastructure...

Allbirds Is Now an AI Company, and That Should Strike Fear Into Anyone Investing in Its Competition

Key PointsAllbirds sold its shoe business and lined up financing to establish a new neocloud business...

62-year-old sports retail giant cuts 100s of jobs

Sportswear is still a growth market, but not every brand is winning equally.North American retail sales of sports-related apparel and footwear were projected to reach $173 billion in 2025 and rise to $209 billion by 2029, according to a McKinsey & Company report.But the report also highlighted that...

Apple After Cook, And Allbirds After Shoes...

Allbirds, Inc. (NASDAQ:BIRD) Short Interest Update

Allbirds, Inc. (NASDAQ:BIRD - Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 432,322 shares, a...

Allbirds' Sudden Pivot to "Newbird AI" Sends Shares Soaring -- but Investors Should Treat This GPUaaS Story With Caution

Key PointsAllbirds shares spiked on chatter of a radical pivot from shoes to an unproven GPU cloud venture...

Smartbird, Inc. is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. It offers Men's Shoes, Women's Shoes, Men's Apparel, Women's Apparel, Socks, and Gift Cards. The company was founded by Timothy Brown and Joseph Zev Zwillinger on May 6, 2015 and is headquartered in Palo Alto, CA.

Smartbird Inc. - Ordinary Shares Class A

Bearish Sentiment

<ul class="summary-bullets"><li>On Wednesday, Allbirds said it has rebranded as Smartbird, Inc., completing its shift toward AI infrastructure.&nbsp;</li><li>Smartbird named former Amazon executive Nadia Carlsten as CEO.</li><li>The company exited most of its retail operations after closing most stores and completing a $39 million asset sale in March.&nbsp;</li></ul>Allbirds (BIRD) grabbed investor attention on Wednesday after the company disclosed a corporate shift that completes its transformation from a footwear company to an artificial intelligence infrastructure provider, helping propel the stock to a one-month high and reflecting growing investor appetite for AI-related businesses.<h2 class="st-heading-2">BIRD Makes&nbsp;Corporate Identity Reset</h2>In an SEC filing on Wednesday, Allbirds said it will now operate as Smartbird, Inc. and unveiled leadership changes, governance updates and expanded financing aimed at supporting a move into AI infrastructure.The changes became effective after the company filed amendments in Delaware on Monday, including the name change and the removal of its public benefit corporation designation.&nbsp;By eliminating references to its public benefit status and adopting the Smartbird name, the company signaled a stronger emphasis on commercial growth opportunities tied to advanced computing and AI-related services.For years, Allbirds was known for environmentally focused sneakers and apparel. That chapter has now effectively ended. By transferring its core consumer assets to American Exchange Group and WSG Brands, the company exited a retail category that had struggled with declining sales and profitability challenges.In April, the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/allbirds-bird-stock-soars-ai-pivot-50m-financing/cZJtXVbRIwe">said</a> it is pivoting to build AI computing infrastructure after securing a $50 million financing deal. It aims to provide customers with reliable, high-performance hardware that is currently in short supply.&nbsp;&nbsp;Allbirds closed most of its physical stores and sold its brand and shoe-related assets to American Exchange Group for $39 million in March.&nbsp;<a href="https://stocktwits.com/symbol/BIRD">Allbirds stock</a> traded more than 2% lower overnight ahead of Thursday,&nbsp;following a broader market selloff on worries about a possible Federal Reserve rate hike to stem inflation.&nbsp;<h2 class="st-heading-2">Leadership And&nbsp;Funding The AI Strategy</h2>The company appointed AI industry and Amazon (AMZN) executive Nadia Carlsten as CEO and President. To support the transition, Smartbird expanded its senior secured convertible note facility, increasing available funding to $100 million. The company plans to use that capital to pursue opportunities in GPU cloud services and private AI computing clusters designed for corporate customers.<h2 class="st-heading-2">What BIRD Retail Traders Are Saying</h2>On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ the previous day, with a 22,600% spike in message volume in 24 hours.&nbsp;A user&nbsp;<a href="https://stocktwits.com/M105/message/656779515">said</a>, “<a href="https://stocktwits.com/symbol/BIRD">$BIRD</a> it’s opening over $20 tomorrow.”Another user&nbsp;<a href="https://stocktwits.com/MaverickVinales/message/656726754">said</a>, “Hopefully this shift plays out. Scooping up an Amazon Exec could help this stock boom.”BIRD stock has gained over 33% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-adbe-crm-ttd-stocks-hit-52-week-lows-today/cZKjp74R7el">Why Did ADBE, CRM, TTD Stocks Hit 52-Week Lows Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of footwear company Allbirds Inc. is displayed on a smartphone in front of abstract background on computer screen. (Photo Illustration by Timon Schneider/SOPA Images/LightRocket via Getty Images)

Allbirds (BIRD) grabbed investor attention on Wednesday after the company disclosed a corporate shift that completes its transformation from a footwear company to an artificial intelligence infrastructure provider, helping propel the stock to a one-month 

Allbirds Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.95
Prev Close	$2.12
Open	$2.11
Dividend Yield	0.00%
50-Day Moving Average	$2.50
Beta	2.16
Avg. Volume	284,863.44
PE Ratio	-0.25

52-Week High	$21.26
52-Week Low	$1.88
Market Capitalization	$25.04M
EPS (Annual)	-$9.47
Price to Book	1.11
Revenue Per Employee	$421,176.80

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIRD Fundamentals